PL2696865T3 - Sposoby zastosowania N-acetylo beta-alaniny - Google Patents

Sposoby zastosowania N-acetylo beta-alaniny

Info

Publication number
PL2696865T3
PL2696865T3 PL12771428T PL12771428T PL2696865T3 PL 2696865 T3 PL2696865 T3 PL 2696865T3 PL 12771428 T PL12771428 T PL 12771428T PL 12771428 T PL12771428 T PL 12771428T PL 2696865 T3 PL2696865 T3 PL 2696865T3
Authority
PL
Poland
Prior art keywords
beta alanine
acetyl beta
methods
alanine methods
acetyl
Prior art date
Application number
PL12771428T
Other languages
English (en)
Inventor
Ronald Kramer
Alexander Nikolaidis
Original Assignee
Thermolife International, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47006851&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2696865(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thermolife International, Llc filed Critical Thermolife International, Llc
Publication of PL2696865T3 publication Critical patent/PL2696865T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL12771428T 2011-04-13 2012-04-13 Sposoby zastosowania N-acetylo beta-alaniny PL2696865T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161475179P 2011-04-13 2011-04-13
US13/446,416 US8802731B2 (en) 2011-04-13 2012-04-13 N-acetyl beta alanine methods of use
EP12771428.5A EP2696865B1 (en) 2011-04-13 2012-04-13 N-acetyl beta alanine methods of use

Publications (1)

Publication Number Publication Date
PL2696865T3 true PL2696865T3 (pl) 2017-07-31

Family

ID=47006851

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12771428T PL2696865T3 (pl) 2011-04-13 2012-04-13 Sposoby zastosowania N-acetylo beta-alaniny

Country Status (8)

Country Link
US (3) US8802731B2 (pl)
EP (1) EP2696865B1 (pl)
AU (1) AU2012242565B2 (pl)
CA (1) CA2833159C (pl)
HU (1) HUE032165T2 (pl)
PL (1) PL2696865T3 (pl)
WO (1) WO2012142474A2 (pl)
ZA (1) ZA201308467B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2903000C (en) * 2013-01-28 2021-10-12 Hector L. Lopez Methods of improving tolerability, pharmacodynamics, and efficacy of .beta.-alanine and use therefor

Family Cites Families (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1916983A (en) 1933-07-04 Gas bubneb
US2176144A (en) 1939-02-04 1939-10-17 Corn Prod Refining Co Method of curing meat
US2553533A (en) 1950-06-17 1951-05-15 Griffith Laboratories Curing process for bacon
US3230036A (en) 1963-09-18 1966-01-18 Frederick A Kappelmann Method for separating americium and curium from the lanthanide rare earths and yttrium
IL25140A (en) 1965-02-15 1970-01-29 Vaessen Schoemaker Holding Bv Additives and methods for improving the quality of protein containing nutrients
DK119643C (da) 1965-04-12 1978-03-13 Ajinomoto Kk Middel til behandling af kod,fortrinsvis i ra tilstand,til forbedring af dets saftighed,farve og morhed
US3997659A (en) 1971-03-30 1976-12-14 The Procter & Gamble Company Hair bleaching compositions containing an arginine compound
JPS531832B2 (pl) 1972-07-03 1978-01-23
US4113715A (en) 1977-01-17 1978-09-12 E. R. Squibb & Sons, Inc. Amino acid derivatives
GB2008578A (en) 1977-11-03 1979-06-06 Sigma Tau Ind Farmaceuti I-Carnitine derivatives
US4379177A (en) 1979-07-05 1983-04-05 The Procter & Gamble Company Stable dehydrated cocrystalline amino acid food additives
US4687782A (en) 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training
AU5410786A (en) 1985-03-04 1986-09-11 Fujisawa Pharmaceutical Co., Ltd. Amino acid derivatives and processes for preparation thereof
US4871550A (en) 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
IL80783A0 (en) 1986-10-17 1987-02-27 Univ Bar Ilan Food supplements
DE68920220T2 (de) 1988-07-19 1995-06-14 Mitsubishi Chem Ind Futterzusatzmittel für Wiederkäuer.
US5026721A (en) 1989-06-05 1991-06-25 Dudrick Stanley J Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition
US5576351A (en) 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
US6451341B1 (en) 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
US5026071A (en) 1990-03-05 1991-06-25 Miraglia Jr Humbert G Word game
CN1049824A (zh) 1990-03-25 1991-03-13 何森 水彩笔芯
CN1022456C (zh) 1990-05-04 1993-10-20 师春生 一种高能营养滋补饮料的制造方法
US5242697A (en) 1990-10-26 1993-09-07 Maurizio Luca Method of preparing nutrified food products
DE4125400C2 (de) 1991-07-31 2000-08-17 Edwin Klaus Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen
US6608109B2 (en) 1991-11-20 2003-08-19 Allen Ann De Wees Composition comprising L-arginine as a muscle growth stimulant and use thereof
DE4222980A1 (de) 1992-07-13 1994-01-20 Cassella Ag Verwendung von 2-(N-(2-Aminoethyl)amino)-essigsäure-derivaten
US5631031A (en) 1994-06-13 1997-05-20 Meade; Thomas L. Water-insoluble amino acid salt
US5543430A (en) 1994-10-05 1996-08-06 Kaesemeyer; W. H. Method and formulation of stimulating nitric oxide synthesis
US20110196039A9 (en) 1994-10-05 2011-08-11 Kaesemeyer Wayne H Controlled release arginine formulations
US6239172B1 (en) 1997-04-10 2001-05-29 Nitrosystems, Inc. Formulations for treating disease and methods of using same
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
US5965596A (en) 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
IT1291127B1 (it) 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1291134B1 (it) 1997-04-08 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato
US20010002269A1 (en) 1997-05-06 2001-05-31 Zhao Iris Ginron Multi-phase food & beverage
DK176196B1 (da) 1997-10-07 2007-01-08 Ejvind Jersie Pedersen Mundhygejnepræparat til behandling af halitosis samt anvendelse af et chelat omfattende en metaliondel og en aminosyredel som en komponent i præparatet
US5904924A (en) 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
US6063432A (en) 1998-05-19 2000-05-16 Cooke Pharma Arginine or lysine containing fruit healthbar formulation
US6277884B1 (en) 1998-06-01 2001-08-21 Nitromed, Inc. Treatment of sexual dysfunction with N-hydroxyguanidine compounds
US6136339A (en) 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
US6159485A (en) * 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US20020119933A1 (en) 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
WO2000069470A2 (en) 1999-05-17 2000-11-23 Aesgen, Inc. Improved cellular uptake of bioactive agents
GB2354441A (en) 1999-08-06 2001-03-28 Mccormack Ltd Composition for treating dentine hypersensitivity
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
US6784209B1 (en) 1999-10-18 2004-08-31 Muscletech Research And Development Inc. Food supplement for increasing lean mass and strength
US7235237B2 (en) 1999-10-29 2007-06-26 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
JP2003517018A (ja) 1999-12-16 2003-05-20 シスキンド，ハリー 栄養組成物、該組成物を製造する方法、及び該組成物を使用する方法
US20020006532A1 (en) 2000-04-26 2002-01-17 Arnaud Robin Bonded LTD-resistant zirconia dental components
CA2410885C (en) 2000-06-02 2010-07-13 Merck Patent Gesellschaft Mit Beschraenkter Haftung Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases
US7816407B2 (en) 2000-06-15 2010-10-19 University Of Kentucky Research Foundation Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders
US20020176881A1 (en) 2001-01-26 2002-11-28 George Verlaan Rehydration composition
US6859771B2 (en) 2001-04-23 2005-02-22 Microsoft Corporation System and method for identifying base noun phrases
US20040097401A1 (en) 2002-11-14 2004-05-20 Debatosh Datta Lysine in therapeutic angiogenesis, particularly in treating ischaemic conditions
ITRM20010445A1 (it) 2001-07-25 2003-01-27 Sigma Tau Healthscience Spa Alfa-chetoglutarati di principi attivi e composizioni che li contengono.
US7740878B2 (en) 2001-10-22 2010-06-22 Danisco A/S Use of betaine to enhance exercise performance
US7054925B2 (en) 2001-11-21 2006-05-30 International Business Machines Corporation Efficient method for determining record based I/O on top of streaming protocols
AU2003208900A1 (en) 2002-01-30 2003-09-02 House Ear Institute L-carnitine for treatment of hearing loss
EP1336602A1 (en) 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
AU2003218099A1 (en) 2002-03-12 2003-09-29 Lsu Medical Center Modulation of the immune response through the manipulation of arginine levels
EP2567705A3 (en) 2002-06-04 2013-07-03 Avicena Group, Inc. Methods of treating cognitive dysfunction by modulating brain energy metabolism
GB0220182D0 (en) 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
MXPA05004290A (es) 2002-10-24 2005-11-23 Enos Pharmaceuticals Inc Formulaciones de l-arginina de liberacion sostenida, y metodos para su fabricacion y uso.
US20050288373A1 (en) 2002-10-24 2005-12-29 Ron Eyal S Methods of treating various conditions by administration of sustained release L-arginine
US20060029668A1 (en) 2002-10-24 2006-02-09 Ron Eyal S Sustained release L-arginine formulations and methods of manufacture and use
US7186692B2 (en) * 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
KR20080022592A (ko) 2002-12-27 2008-03-11 다이이찌 세이야꾸 가부시기가이샤 미백용 조성물
EP1586332A4 (en) * 2003-01-20 2009-11-11 Innovative Vision Products Inc COMBINED USE OF CARNOSINAS INHIBITOR WITH L-CARNOSINES AND COMPOSITION
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
US20060063827A1 (en) * 2004-09-23 2006-03-23 Yu Ruey J Systemic administration of therapeutic amino acids and N-acetylamino acids
AU2004255268B2 (en) 2003-07-09 2010-04-01 Loma Linda University Use of nitrite salts for the treatment of cardiovascular conditions
WO2005023272A1 (en) 2003-08-22 2005-03-17 Howard Murad Pharmaceutical compositions and methods for lowering blood pressure and pulse rate
US20050053673A1 (en) 2003-09-05 2005-03-10 Shrirang Netke Composition and method for facilitating bone healing
WO2005027015A2 (en) 2003-09-10 2005-03-24 Bioimagene, Inc. Method and system for quantitatively analyzing biological samples
JP2007521324A (ja) 2003-09-29 2007-08-02 エノス ファーマシューティカルズ， インク． 徐放性ｌ−アルギニン調合物並びにその製造法及び使用法
WO2005055947A2 (en) * 2003-12-08 2005-06-23 Yu Ruey J Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions
EP1703795A4 (en) 2003-12-31 2011-01-19 Yosi Shevach SUGAR BEET PRODUCTS
JP4813023B2 (ja) 2004-03-03 2011-11-09 日本新薬株式会社 保健食品、及び薬剤
WO2005107735A2 (en) 2004-04-30 2005-11-17 Pump Formulations, Ltd. Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, incresing nutrient delivery and/or promoting increased vascular response in a
GB0411985D0 (en) 2004-05-28 2004-06-30 Howard Foundation Holdings Ltd Food compositions containing creatine
US7362274B1 (en) 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US7873012B2 (en) 2004-07-26 2011-01-18 Avaya Communication Israel Ltd. Roaming wireless client communication
KR100966318B1 (ko) 2004-09-02 2010-06-28 코스모세키유 가부시키가이샤 건강 기능 향상제
CN1631539A (zh) 2004-12-03 2005-06-29 北京大学 氨基酸盐离子液体及其制备方法
US20070141174A1 (en) 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
CA2537647A1 (en) 2005-03-01 2006-09-01 Six Star Formulations Ltd. Supplemental dietary composition for supporting muscle growth, recovery and strength
WO2006127761A1 (en) 2005-05-26 2006-11-30 Pediatrix Medical Group, Inc. Nutrition formulations and methods of providing nutrition formulations
EP1913943B1 (en) 2005-06-27 2011-09-21 Kyowa Hakko Bio Co., Ltd. Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria
US20070105817A1 (en) 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
US8153692B2 (en) 2005-12-05 2012-04-10 Kyowa Hakko Bio Co., Ltd. Oral preparation for preventing or improving skin dryness
EP1889625A1 (en) 2006-07-17 2008-02-20 Pharmaton S.A. Dietary supplement for supporting mental and physical performance
WO2008067641A1 (en) 2006-12-06 2008-06-12 H3 Formulations Ltd. Composition for improving blood flow in working muscles comprising l-arginine, crataegus extract and artichoke flavonoids
US10406118B2 (en) 2007-02-26 2019-09-10 Jon Lundberg Use of nitrites and nitrates and compositions containing these
JP2010519335A (ja) 2007-02-26 2010-06-03 ルンドベルク，ヨン 運動能力向上組成物及びその使用
US7850997B2 (en) 2007-03-21 2010-12-14 Tim Romero Dietary compositions and methods of enhancing lean body mass and exercise performance
EP1982604A1 (de) 2007-04-20 2008-10-22 Naturheilzentrum Allgäu Nahrungsergänzungsmittel zum Ausgleich von Nährstoffmangel
US8569369B2 (en) 2007-09-18 2013-10-29 Thermolife International, Llc Amino acid compounds
US8455531B2 (en) 2007-09-18 2013-06-04 Thermolife International, Llc Amino acid compositions
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US8569368B2 (en) 2007-09-18 2013-10-29 Thermolife International, Llc Amino acid compounds
US8048921B2 (en) 2007-09-18 2011-11-01 Ronald Kramer Amino acid compounds
US7777074B2 (en) 2007-09-18 2010-08-17 Thermolife International, Llc Amino acid compounds
US20090280199A1 (en) 2007-11-01 2009-11-12 Aaken Laboratories, Inc. Neuroprotective Compositions and Methods of Using Same
US20110123654A1 (en) 2008-06-06 2011-05-26 Ralf Jaeger Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon
US8916612B2 (en) 2008-09-11 2014-12-23 Gad Gilad Agmatine containing dietary supplements, nutraceuticals, and foods
US8703719B1 (en) 2009-05-18 2014-04-22 Bio-Engineered Supplements And Nutrition, Inc. Method and composition for improved muscle performance
KR20110015141A (ko) 2009-08-07 2011-02-15 주식회사 셀트리온제약 피페라진 다이티옥트산염 및 아세틸-ｌ-카르니틴을 포함하는 약제학적 조성물
US20110064712A1 (en) 2009-09-16 2011-03-17 Daniel Moses Amato Dietary Supplement Compositions and Methods of Making and Using the Same
US9271983B2 (en) 2010-03-26 2016-03-01 Bioadatp, Llc Composition for enhancing athletic performance
GB2523578A (en) 2014-02-28 2015-09-02 Daniel Nelson A nutritional supplement
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
EP3975754A1 (en) 2019-05-28 2022-04-06 Mayo Foundation for Medical Education and Research Nutritional health supplements

Also Published As

Publication number Publication date
WO2012142474A3 (en) 2012-12-27
EP2696865B1 (en) 2016-12-21
US20140350108A1 (en) 2014-11-27
US8802731B2 (en) 2014-08-12
US20140350109A1 (en) 2014-11-27
US11534419B2 (en) 2022-12-27
CA2833159A1 (en) 2012-10-18
WO2012142474A2 (en) 2012-10-18
EP2696865A4 (en) 2014-10-15
AU2012242565A1 (en) 2013-11-07
AU2012242565B2 (en) 2017-05-11
CA2833159C (en) 2019-08-06
HUE032165T2 (en) 2017-09-28
ZA201308467B (en) 2014-08-27
EP2696865A2 (en) 2014-02-19
US20120264826A1 (en) 2012-10-18

Similar Documents

Publication Publication Date Title
EP2683693A4 (en) ROR-GAMMA-T INHIBITORS
PL2770871T3 (pl) Szczoteczka do zębów
AU337152S (en) Watch
EP2755524A4 (en) TOOTHBRUSH
AU337151S (en) Watch
EP2746362A4 (en) SCINTILLATOR
EP3701800C0 (en) USE
HK1179359A1 (en) Wristwatch
EP2708155A4 (en) TOOTHBRUSH
EP2726839A4 (en) SAMPLER
EP2767257A4 (en) ARTICULATOR
GB201119774D0 (en) IBS treatment
PL2691770T3 (pl) Prekoncentrator
GB201111742D0 (en) Solution
EP2753678A4 (en) TREATMENT OF COAL
EP2719301A4 (en) MASCARA
IL232239A0 (en) Medical use
ZA201308101B (en) Diagnostic use of prosomatostatin
HK1174525A1 (zh) 咬合器
ZA201308467B (en) N-acetyl beta alanine methods of use
GB201211329D0 (en) Improved electrical timeswitch
GB2489959B (en) Pyrolyser
EP2741082A4 (en) SAMPLER
EP2792044A4 (en) VOLTAGE MEASUREMENT
GB201120123D0 (en) Dental insrument